Covetrus Inc represents a set of core values and a strong corporate philosophy. The company is committed to providing comprehensive animal healthcare solutions with compassion and innovation. Covetrus aims to improve the well-being and longevity of animals, while supporting the success of veterinary professionals through a client-centric approach. With a focus on excellence, collaboration, and integrity, Covetrus ensures the delivery of high-quality products, services, and technology solutions to meet the evolving needs of the animal healthcare industry. The company's dedication to ethical practices and sustainability further exemplifies their commitment to both their customers and the global community.

Covetrus Inc is primarily present in multiple countries and regions worldwide. The company has a global reach, with a strong presence in North America, Europe, and Asia. Covetrus serves customers in the United States, Canada, the United Kingdom, Germany, France, Italy, Spain, the Netherlands, China, and several other countries. With its expansive international footprint, Covetrus aims to meet the diverse needs of veterinary practices and animal health professionals across different markets and geographies.

Covetrus Inc, a leading global animal-health technology and services company, has achieved significant milestones since its establishment. The company has successfully expanded its product portfolio, offering a comprehensive range of veterinary supplies, medications, and clinical services to support animal healthcare providers. Covetrus Inc has also implemented innovative technologies to enhance efficiency and streamline operations, driving growth and improving customer satisfaction. Additionally, the company has made strategic acquisitions and partnerships to strengthen its global presence and expand its offerings in the animal health industry. Covetrus Inc continues to demonstrate its commitment to advancing animal healthcare through continuous innovation and strategic initiatives.

Covetrus Inc is a leading global animal health technology and services company. It was formed in 2019 as a result of a merger between Vets First Choice and Henry Schein Animal Health. With a rich history, Covetrus has roots that date back to the mid-1990s when Vets First Choice was first established. Over the years, the company has evolved, expanded its offerings, and developed innovative solutions to support veterinary professionals and animal health. Covetrus now operates in more than 25 countries, serving over 100,000 customers worldwide. Its comprehensive portfolio includes practice management software, pharmacy services, online pharmacy platforms, and supply chain solutions, all aimed at improving the health and well-being of animals.

The main competitors of Covetrus Inc in the market include IDEXX Laboratories, Inc., Patterson Companies, Inc., and Henry Schein, Inc.

Covetrus Inc is primarily active in the animal health industry. With its comprehensive range of products, technologies, and services, Covetrus aims to improve the health and well-being of animals worldwide. Serving both veterinary practices and pet owners, Covetrus offers innovative solutions for pharmaceuticals, digital imaging, practice management software, and more. As a global leader in animal health, Covetrus leverages its expertise to provide high-quality care and support for companion animals, livestock, and other creatures.

The business model of Covetrus Inc is to provide technology-enabled services and solutions for the veterinary market. As a leading global animal health technology and services company, Covetrus offers a comprehensive suite of software, pharmacy, and supply chain solutions for veterinary practices, clinics, and hospitals. By harnessing the power of technology, Covetrus aims to enhance patient care, improve practice efficiency, and streamline the veterinary supply chain. With a strong focus on innovation and customer-centric offerings, Covetrus continues to empower veterinary professionals with advanced tools and resources to deliver quality care to animals worldwide.

Коефициентът на цена спрямо печалбата (КЦП) на Covetrus е 13,10.

Коефициентът на цена към оборот (KUV) на Covetrus е 0,50.

AlleAktien качественият резултат за Covetrus е 3/10.

очаквана Covetrus оборотът е 5,79 млрд. USD.

очаквана Covetrus печалба е 219,54 млн. USD.

Covetrus Inc. is a leading company in the animal health industry, offering a wide range of solutions and products used by veterinarians, animal clinics, and other companies in the animal health sector. The company was founded in February 2019 when the two companies Vets First Choice and Henry Schein Animal Health merged. Covetrus Inc. provides its customers with a comprehensive platform that allows them to run their business more effectively, increase their revenue, and better serve their customers. The platform includes a variety of tools and services, including e-commerce solutions, practice management software, customized marketing solutions, veterinary products, and more. E-commerce solutions: Covetrus Inc. provides merchants and veterinarians with a platform that enables them to sell their goods online while better serving their customers. The platform is fully customizable and can be tailored to the specific requirements of each merchant. Practice management software: Covetrus Inc. offers a wide range of solutions to help veterinarians and animal clinics operate their practice more effectively. This includes solutions such as simplifying appointment scheduling, billing, invoicing, patient and inventory management, and a variety of other tools to optimize workflow in the practice. Marketing solutions: Covetrus Inc. works closely with its customers to develop customized marketing solutions that are specifically tailored to the needs and requirements of each company. This includes solutions such as developing and implementing advertising campaigns, emails, social media marketing, and more. Veterinary products: Covetrus Inc. offers a wide range of veterinary products used by veterinarians and animal clinics. The products range from diagnostic tests to surgical instruments, providing top quality and reliability. Covetrus Inc. operates in various regions of the world, including North America, Europe, Asia, and Australasia. The company pursues a strategy of continuous improvement and innovation to constantly provide its customers with new and improved solutions. It works closely with its customers to ensure that its products and services meet their requirements and needs. Overall, Covetrus Inc. is a leading company in the animal health industry that offers its customers a wide range of solutions and products. From e-commerce solutions to veterinary products, Covetrus Inc. has an industry-leading platform that allows its customers to run their business more effectively while better serving their customers.

Covetrus разпределя дивидента от 0 USD на плащания годишно.

Дивидентата за Covetrus в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Covetrus е US22304C1009.

WKN на Covetrus е A2PBX0.

Тикерът на Covetrus е CVET.

През последните 12 месеца Covetrus изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Covetrus да изплати дивиденда в размер на 0 USD.

Дивидентната доходност на Covetrus в момента е .

Covetrus изплаща дивидент на тримесечие. Той се разпределя в месеците .

Covetrus платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 USD. Това съответства на дивидентна доходност от 0 %.

Covetrus се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Covetrus на 14.02.2025 г. в размер на 0 USD, трябваше да притежавате акцията в портфейла си преди Ex-деня на 14.02.2025 г..

Последното дивидентно плащане беше извършено на 14.02.2025 г..

През година 2024 Covetrus изплати 0 USD под формата на дивиденти.

Дивидентите от Covetrus се изплащат в USD.